Physician profile
Luke Elms
NPI 1962723635
$12,558.32
in general payments reported to CMS, 2019-2025
15 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $95.91 · 2022: $3,267 · 2023: $158 · 2024: $8,440 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $747.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,779.79 | 2022-2024 | |
| Ethicon INC. | $1,882.20 | 2022-2023 | Stratafix |
| Davol INC. | $183.48 | 2020-2024 | Phasix Mesh |
| Acell, INC. | $144.01 | 2019-2020 | |
| Bard Access Systems, INC. | $140.35 | 2019 | |
| Ethicon US, LLC | $124.38 | 2025 | Dermabond Prineo, Vistaseal |
| Medtronic USA, INC. | $123.04 | 2019 | |
| Integra Lifesciences Corporation | $35.33 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $26.05 | 2019 | |
| Medtronic, INC. | $24.70 | 2025 | |
| Tela Bio, INC. | $23.81 | 2022 | |
| Smith+Nephew, INC. | $20.70 | 2020 | |
| Tei Biosciences INC | $18.98 | 2019 | |
| Trevena, INC. | $17.30 | 2022 | |
| Checkpoint Surgical, INC | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Elms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.